Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -0.81%19 ROA % is 4.57% as of Jun. 2026, which is 70% below its 10-year median of 15.23. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Medeze Group PCL ranks better than 61.86% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Medeze Group PCL's annualizedNet Income for the quarter that ended in Jun. 2026 was ฿160.7 Mil.
Medeze Group PCL's average Total Assets over the quarter that ended in Jun. 2026 was ฿3,513.9 Mil. Therefore, Medeze Group PCL's annualized ROA % for the quarter that ended in Jun. 2026 was 4.57%.
The historical rank and industry rank for Medeze Group PCL's ROA % or its related term are showing as below:
BKK:MEDEZE'
s ROA % Range Over the Past 10 Years
Min: 4.04 Med: 15.23 Max: 23.51
Current: 4.04
During the past 3 years, Medeze Group PCL's highest ROA % was 23.51%. The lowest was 4.04%. And the median was 15.23%.
BKK:MEDEZE's ROA % is ranked better than 61.86% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs BKK:MEDEZE: 4.04
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Medeze Group PCL ROA % Related Terms
Medeze Group PCL ROA % Historical Data
* Premium members only.
The historical data trend for Medeze Group PCL's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medeze Group PCL's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's ROA % distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Medeze Group PCL (BKK:MEDEZE) has a ROA % of 4.57% as of Jun. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Medeze Group PCL and its competitors. This is 70% below median its historical median of 15.23. Over the past decade, Medeze Group PCL's ROA % has ranged from 4.04 to 23.51. According to the industry distribution chart, Medeze Group PCL ranks #262 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 38.1%.
Is Medeze Group PCL's ROA % too high?
Medeze Group PCL's current ROA % of 4.57% is 70% below median its 10-year median of 15.23. Over the past 10 years, this metric has ranged from a low of 4.04 to a high of 23.51. The Healthcare Providers & Services industry median ROA % is 2.05. Medeze Group PCL's value of 4.57% is 122.9% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #262 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #262 out of 687 companies for ROA %. This puts Medeze Group PCL in the upper half of its industry. The industry median ROA % is 2.05. Medeze Group PCL's value of 4.57% is 122.9% above this benchmark. Historically, Medeze Group PCL's own ROA % has ranged from 4.04 to 23.51 over the past decade. While the company's 10-year median is 15.23 vs. the industry median of 2.05, Medeze Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 2.05, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current ROA % of 4.57% is 122.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current ROA % is 4.57%, which is 70% below median its own 10-year median of 15.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current ROA % of 4.57%. The current ROA % is 4.57%, which is 70% below median its 10-year median of 15.23 and 122.9% above the Healthcare Providers & Services industry median of 2.05. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current ROA % is 4.57% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
